Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa
  • Amsterdam
  • Berlin
  • Brussels
  • Copenhagen
  • Danske Bank
  • Denmark
  • DFDS
  • DSV
  • Faroe Islands
  • Greenland
  • Helsinki
  • LEGO
  • Mærsk
  • Novo Nordisk
  • Ørsted
  • Oslo
  • Riga
  • Stockholm
  • Tallinn
  • Vestas Wind Systems
  • Vilnius
  • Warsaw
Denmark
  • Europe
    • FR
    • DE
    • IT
    • ES
    • PL
    • BE
    • NL
    • LU
    • CH
    • NO
    • SE
    • FI
    • EE
    • LV
    • LT
  • Denmark
    • Faroe Islands
    • Greenland
    • Copenhagen
  • Business
    • Mærsk
    • Novo Nordisk
    • DSV
    • Ørsted
    • Danske Bank
    • Vestas Wind Systems
    • LEGO
    • DFDS
  • Nordics
    • Stockholm
    • Oslo
    • Helsinki
  • Baltics
    • Tallinn
    • Riga
    • Vilnius
  • Benelux
    • Brussels
    • Amsterdam
  • Warsaw
  • Berlin
  • NATO
  • UK
  • US
  • Africa

Browsing Tag

Bets

8 posts
NNovo Nordisk
Novo Nordisk Bets on Oral Access and Combination Research to Revive Growth Story
Read More

Novo Nordisk Bets on Oral Access and Combination Research to Revive Growth Story

  • 2026-06-05
Novo Nordisk launches oral Wegovy in UAE (first outside US) and tests combination with Veru for older adults.…
NNovo Nordisk
Novo Nordisk Bets on Buybacks and Pipeline Data as Prescription Boom Meets Washington Pricing Pressu
Read More

Novo Nordisk Bets on Buybacks and Pipeline Data as Prescription Boom Meets Washington Pricing Pressu

  • 2026-06-02
Novo Nordisk’s oral obesity therapy drives 2M prescriptions in 5 months, but shares tumble 48% from peak amid…
NNovo Nordisk
Novo Nordisk Bets on CagriSema and Oral Wegovy to Counter Pricing Headwinds and Analysts' Caution
Read More

Novo Nordisk Bets on CagriSema and Oral Wegovy to Counter Pricing Headwinds and Analysts’ Caution

  • 2026-05-31
Novo Nordisk faces key test at ADA with CagriSema Phase 3 data; Wegovy oral prescriptions surge, European reimbursement…
NNovo Nordisk
Novo Nordisk Bets on Oral Pill and CagriSema to Reclaim Obesity Leadership After 60% Sell-Off
Read More

Novo Nordisk Bets on Oral Pill and CagriSema to Reclaim Obesity Leadership After 60% Sell-Off

  • 2026-05-15
Novo Nordisk rallies on oral Wegovy’s 21.6% weight loss, bests Lilly; CagriSema submitted for US approval. Stock up…
NNovo Nordisk
Novo Nordisk Scraps Rare-Disease Factory, Bets on Oral Obesity Pill and CagriSema to Revive Growth
Read More

Novo Nordisk Scraps Rare-Disease Factory, Bets on Oral Obesity Pill and CagriSema to Revive Growth

  • 2026-05-14
Novo Nordisk pivots from rare diseases to obesity, scrapping a Danish plant and 400 jobs, as it races…
NNovo Nordisk
Novo Nordisk’s One-Time Windfall Masks a Deeper Squeeze as Pipeline Bets Take Shape
Read More

Novo Nordisk’s One-Time Windfall Masks a Deeper Squeeze as Pipeline Bets Take Shape

  • 2026-05-08
Novo Nordisk’s Q1 profit surged on a one-off accounting gain, but US sales fell 11% amid pricing pressure.…
NNovo Nordisk
Novo Nordisk Bets on AI and Subscriptions to Counter a Steep Slide
Read More

Novo Nordisk Bets on AI and Subscriptions to Counter a Steep Slide

  • 2026-04-19
Novo Nordisk shares surge as the firm partners with OpenAI to accelerate drug development and expands Wegovy subscription…
NNovo Nordisk
Novo Nordisk Bets on AI and New Products to Reverse Steep Share Slide
Read More

Novo Nordisk Bets on AI and New Products to Reverse Steep Share Slide

  • 2026-04-16
Novo Nordisk shares rebound on UK Wegovy pen approval. The firm combats a weak outlook with an OpenAI…
Denmark
www.europesays.com